Day 2 - Welcome
Chair: Rodney Falk (Boston, US)
Session 2.1: Advances in Cardiomyopathy: Clinical Trial Updates
Chair: Rodney Falk (Boston, US)
Panel: Esther Gonzalez Lopez (Madrid, ES); Ahmad Masri (Portland, US); Fabian Knebel (Berlin, DE)
-
Disease-modifying Treatments in ATTR and AL - Esther Gonzalez Lopez
-
Advances in HCM (obstructive and non-obstructive) - Ahmad Masri
-
Emerging Prognostic Biomarkers - Fabian Knebel
-
Audience Q&A
Session 2.2: Personalising Treatment in Amyloidosis
Chair: Margot Davis (Vancouver, CA)
Panel: Joao Agostinho (Lisbon, PT); Ahmad Masri (Portland, US)
-
Optimising Treatment in ATTR: Sequencing Therapies and Biomarkers - Joao Agostinho
-
Sequencing therapies in ATTR
-
Biomarkers and surrogate endpoints in amyloidosis research
-
-
Disparities in Clinical Trials: Gap Between Race and Gender - Margot Davis
-
Gaps in Guidelines; Gaps in Evidence: New Guideline Development - Ahmad Masri
-
Audience Q&A
Session 2.3: HCM and Comorbidity Management
Chair: Iacopo Olivotto (Florence, IT)
Panel: Alessia Argiro (Florence, IT); Juan Pablo Ochoa (Madrid, ES); Juan Pablo Kaski (London, UK)
-
Common HCM Phenocopies - Alessia Argiro
-
Genetics of HCM - Juan Pablo Ochoa
-
Managing HCM in the Young - Juan Pablo Kaski
-
Audience Q&A
Day 2 - Summary
Chair: Iacopo Olivotto (Florence, IT)
Day 1 - Welcome
Chair: Rodney Falk (Boston, US)
Session 1.1: Sonography 101 – Diagnosing and Monitoring Cardiomyopathies
Chair: Rodney Falk (Boston, US)
Panel: Iacopo Olivotto (Florence, IT); Sheila Hegde (Dallas, US); Ahmad Masri (Portland, US)
Challenging Patient Case: mixed symptoms suggestive of cardiomyopathy; X-ray confirmed cardiac aetiology - Rodney Falk
Echocardiography results presented
Audience polling: most likely diagnosis based on echo features; what next?
Echocardiography Workshop 1: HCM - Sheila Hegde
Echocardiography Workshop 2: Cardiac Amyloidosis - Ahmad Masri
Audience Q&A
Session 1.2: CT, CMR and Nuclear Imaging in Diagnosis and Monitoring
Chair: Margot Davis (Vancouver, CA)
Panel: Sarah Cuddy (Boston, US); Arnt Kristen (Heidelberg, DE)
CMR Workshop - Sarah Cuddy
Nuclear Imaging: What Cardiologists Need to Know - Arnt Kristen
Audience Q&A
Session 1.3: Case Conclusion
Chair: Rodney Falk (Boston, US)
Panel: Iacopo Olivotto (Florence, IT); Ahmad Masri (Portland, US)
-
Case Conclusion - Rodney Falk
-
Discussion and Faculty Q&A
Session 1.4: Future of Imaging in Cardiomyopathy
Chair: Margot Davis (Vancouver, CA)
Panel: Sharmila Dorbala (Boston, US); Giorgia Panichella (Florence, IT); Elena Arbelo (Barcelona, ES)
Unmet Needs of Imaging in Diagnosis and Monitoring - Sharmila Dorbala
Assessing the Impact of AI - Giorgia Panichella
Imaging in HCM - Elena Arbelo
Monitoring and risk stratification
Future/ongoing trials
Audience Q&A
Day 1 - Summary
Chair: Margot Davis (Vancouver, CA)